Table 1. Clinical details of study participants included in the cohort stratified by HIV status.
Clinical parameter | Total N = 468 | HIV—N = 253 | HIV + N = 215 |
---|---|---|---|
Median age [IQR] | 38 [31–45] | 38 [29–48] | 38 [31–43] |
HIV+ on ART | n/a | n/a | 153 (71%) |
HIV+ not on ART | 48 (22%) | ||
Missing ART information | 14 (7%) | ||
Median CD4 counts [IQR (cells/μl)] | n/a | n/a | 422 [245–614] |
Pathological diagnosis† | N = 440 | N = 240 | N = 200 |
CC | 32 (7%) | 16 (7%) | 16 (8%) |
HSIL | 13 (3%) | 6 (3%) | 7 (4%) |
LSIL | 15 (3%) | 5 (2%) | 10 (5%) |
No lesion | 380 (86%) | 213 (89%) | 167 (84%) |
Cervical HPV diagnosis | N = 213 | N = 113 | N = 100 |
HPV infected | 122 (57%) | 47 (42%) | 75 (75%) |
† pathology diagnosis based on cytology and confirmed by histology
CC = cervical cancer, HSIL = high grade intraepithelial lesion, LSIL = low grade intraepithelial lesion, ART = antiretroviral therapy